The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.
Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results